PROCEPT BioRobotics Statistics Share Statistics PROCEPT BioRobotics has 55.64M
shares outstanding. The number of shares has increased by 2.28%
in one year.
Shares Outstanding 55.64M Shares Change (YoY) 2.28% Shares Change (QoQ) 0.56% Owned by Institutions (%) 91.85% Shares Floating 53.56M Failed to Deliver (FTD) Shares 68,699 FTD / Avg. Volume 5.98%
Short Selling Information The latest short interest is 8.15M, so 14.64% of the outstanding
shares have been sold short.
Short Interest 8.15M Short % of Shares Out 14.64% Short % of Float 17.35% Short Ratio (days to cover) 7.74
Valuation Ratios The PE ratio is -45.91 and the forward
PE ratio is -35.44.
PROCEPT BioRobotics's PEG ratio is
2.1.
PE Ratio -45.91 Forward PE -35.44 PS Ratio 18.7 Forward PS 4.5 PB Ratio 10.43 P/FCF Ratio -40.5 PEG Ratio 2.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for PROCEPT BioRobotics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.07,
with a Debt / Equity ratio of 0.2.
Current Ratio 9.07 Quick Ratio 8.01 Debt / Equity 0.2 Debt / EBITDA -0.98 Debt / FCF -0.77 Interest Coverage -23.09
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $296.96K Profits Per Employee $-120.92K Employee Count 756 Asset Turnover 0.42 Inventory Turnover 1.56
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -53.17% in the
last 52 weeks. The beta is 1.02, so PROCEPT BioRobotics's
price volatility has been higher than the market average.
Beta 1.02 52-Week Price Change -53.17% 50-Day Moving Average 41.27 200-Day Moving Average 57.99 Relative Strength Index (RSI) 35.07 Average Volume (20 Days) 1,149,225
Income Statement In the last 12 months, PROCEPT BioRobotics had revenue of 224.5M
and earned -91.41M
in profits. Earnings per share was -1.75.
Revenue 224.5M Gross Profit 137.1M Operating Income -96.61M Net Income -91.41M EBITDA -82M EBIT -87.23M Earnings Per Share (EPS) -1.75
Full Income Statement Balance Sheet The company has 333.73M in cash and 80.25M in
debt, giving a net cash position of 253.47M.
Cash & Cash Equivalents 333.73M Total Debt 80.25M Net Cash 253.47M Retained Earnings -545.99M Total Assets 513.05M Working Capital 408.34M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -99.21M
and capital expenditures -4.41M, giving a free cash flow of -103.62M.
Operating Cash Flow -99.21M Capital Expenditures -4.41M Free Cash Flow -103.62M FCF Per Share -1.99
Full Cash Flow Statement Margins Gross margin is 61.07%, with operating and profit margins of -43.04% and -40.72%.
Gross Margin 61.07% Operating Margin -43.04% Pretax Margin -40.72% Profit Margin -40.72% EBITDA Margin -36.52% EBIT Margin -43.04% FCF Margin -46.16%
